DaehanPharmaceutical Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - DaehanPharmaceutical

Watchlist Manager

Watchlist

Price: 25 900 KRW -0.19% Market Closed

Market Cap: ₩155.4B

D	DaehanPharmaceutical KOSDAQ:023910	KR
A	Axon Partners Group SA MAD:APG	ES
	Repsol SA F:REP	ES
	Fiducian Group Ltd ASX:FID	AU
	Clara Resources Australia Ltd F:0H8A	AU
H	Hasen-Immobilien AG XMUN:ABHA	DE
C	Chun Zu Machinery Industry Co Ltd TPEX:4544	TW
O	Orosur Mining Inc F:UR2	CA
M	Movado Group Inc F:MV4	US
	Lighthouse Properties PLC F:87O	MT
F	Falco Resources Ltd SWB:8FP	CA
C	Credit Corp Group Ltd OTC:CCGFF	AU

Profitability Summary

DaehanPharmaceutical's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

30%

Sustainable 3Y Average Gross Margin

33%

Declining Gross Margin

33% > 30%

Healthy Operating Margin

14%

Sustainable 3Y Average Operating Margin

17%

Declining Operating Margin

18% > 14%

Healthy Net Margin

13%

Sustainable 3Y Average Net Margin

15%

Declining Net Margin

13% > 13%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

12% > 9%

Low ROE

Positive 3Y Average ROE

Positive 3Y Average ROIC

15%

Declining ROIC

16% > 11%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.